Side-by-side financials for ANIX and JNJ. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANIX | JNJ |
|---|---|---|
| Market cap | - | $579.83 B |
| US-listed rank | - | #20 |
| Revenue (latest FY) | $210.00K | $94.19B |
| Net income (latest FY) | -$10.93M | $26.80B |
| Net margin | -5203.3% | 28.5% |
| P/E (trailing FY) | - | 21.6 |
| SEC filings | 960 | 984 |
Full pages: Anixa Biosciences Inc and JOHNSON & JOHNSON, or browse the full rankings.